Ken Griffin Neuroone Medical Technologies Corp Call Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.86 - $1.92 $2,494 - $5,568
2,900 Added 24.37%
14,800 $23,000
Q3 2023

Nov 14, 2023
BUY
$0.85 - $1.99 $10,115 - $23,681
11,900 New
11,900 $10,000
Q4 2022

Feb 14, 2023
BUY
$0.84 - $2.82 $6,132 - $20,586
7,300 New
7,300 $8,000

Others Institutions Holding NMTC

# of Institutions
22
Shares Held
2.42M
Call Options Held
0
Put Options Held
0
View Full List

About NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC Quotes by TradingView
  • Ticker NMTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,209,200
  • Market Cap $19.6M
  • Description
  • NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...
More about NMTC
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email